The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa

References

• Hotez PJ, Alvarado M, Basanez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014;8:e2865
   PubMed Web of Science ®Google Scholar
• Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. Crompton DW, Peters P, Editors. World Health Organisation; Geneva: 2010
   Google Scholar
• Crump A, Morel CM, Omura S. The onchocerciasis chronicle: from the beginning to the end? Trends Parasitol 2012;28:280-8
   PubMed Web of Science ®Google Scholar
• Elimination of onchocerciasis in the WHO Region of the Americas: Ecuador’s progress towards verification of elimination. Wkly Epidemiol Rec 2014;89:401-5
   PubMedGoogle Scholar
• Dadzie Y, Neira M, Hopkins D. Final report of the Conference on the eradicability of Onchocerciasis. Filaria J 2003;2:2
   PubMedGoogle Scholar
• Diawara L, Traore MO, Badji A, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009;3:e497
   PubMed Web of Science ®Google Scholar
• Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. Ouagadougou: African Programme for Onchocerciasis Control, 2010
   Google Scholar
• Accelerating work to overcome the global impact of neglected tropical diseases: A roadmap for implementation. Crompton DW, Editor. World Health Organisation; Geneva: 2012
   Google Scholar
• Mectizan Donation Program: What we do. Decatur, GA: Mectizan Donation Program, 2015. Available from: http://www.mectizan.org/about/what-we-do [Last accessed 8 April 2015]
   Google Scholar
• Kim YE, Remme JH, Steinmann P, et al. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis 2015;9:e0003664
   PubMed Web of Science ®Google Scholar
• Katabarwa MN, Lakwo T, Habomugisha P, et al. Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 Years of a single dose of annual treatment with ivermectin. Am J Trop Med Hyg 2013;89:293-300
   PubMed Web of Science ®Google Scholar
• Wanji S, Kengne-Ouafo JA, Esum ME, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of south west cameroon after a decade of ivermectin treatment. Parasit Vectors 2015;8:202
   PubMed Web of Science ®Google Scholar
• Osei-Atweneboana MY, Eng JK, Boakye DA, et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007;369:2021-9
   PubMed Web of Science ®Google Scholar
• Nana-Djeunga HC, Bourguinat C, Pion SD, et al. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naive and a frequently treated population from Cameroon. PLoS Negl Trop Dis 2014;8:e2824
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Hoerauf A, Townson S, et al. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology 2014;141:119-27
   PubMed Web of Science ®Google Scholar
• Makepeace BL, Jensen SA, Laney SJ, et al. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. PLoS Negl Trop Dis 2009;3:e544
   PubMed Web of Science ®Google Scholar
• Babayan SA, Luo H, Gray N, et al. Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes. PLoS Negl Trop Dis 2012;6:e1968
   PubMed Web of Science ®Google Scholar
• Hess JA, Zhan B, Bonne-Annee S, et al. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. Int J Parasitol 2014;44:637-46
   PubMed Web of Science ®Google Scholar
• Arumugam S, Wei J, Ward D, et al. Vaccination with a genetically modified Brugia malayi cysteine protease inhibitor-2 reduces adult parasite numbers and affects the fertility of female worms following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae. Int J Parasitol 2014;44:675-9
   PubMed Web of Science ®Google Scholar
• Onchocerca volvulus (PRJEB513). [WormBase ParaSite]. Hinxton, Cambridge, UK: EMBL - EBI 2015. Available from: http://parasite.wormbase.org/Onchocerca_volvulus_prjeb513/Info/Index/ [Last accessed 8 April 2015]
   Google Scholar
• Hotez PJ, Bottazzi ME, Zhan B, et al. The onchocerciasis vaccine for africa–TOVA–initiative. PLoS Negl Trop Dis 2015;9:e0003422
   PubMed Web of Science ®Google Scholar